First Trust NYSE Arca Biotechnology Index Fund Rating $165.91 -0.67 (-0.40%) As of 11:08 AM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock First Trust NYSE Arca Biotechnology Index Fund Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FBT Aggregate RatingModerate Buy 2.66Holdings in FBT have an aggregate rating of Moderate Buy based on 539 analyst ratings issued in the past year covering 30 companies (99.9% of the portfolio).FBT Aggregate Price Target$165.63-0.17% DownsideHigh Prediction$165.63Average Prediction$165.63Low Prediction$165.63Holdings in FBT have an aggregate price target of $165.63 and a range of $165.63 to $165.63 covering 30 companies (99.9% of the portfolio).FBT Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy5 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust NYSE Arca Biotechnology Index Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 30 FBT Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.77%ACADACADIA Pharmaceuticals$21.14+0.7%4.7174 of 5 stars2.71$27.88 31.9%17Positive NewsAnalyst Revision4.36%NBIXNeurocrine Biosciences$134.36+0.7%4.5328 of 5 stars2.87$163.91 22.0%23Insider TradeAnalyst Revision4.19%ALNYAlnylam Pharmaceuticals$316.59+0.5%4.174 of 5 stars2.80$345.70 9.2%25Positive NewsAnalyst Forecast3.94%ILMNIllumina$98.96-0.3%4.8681 of 5 stars2.40$125.11 26.4%20Positive NewsAnalyst Downgrade3.90%INCYIncyte$68.99+0.6%4.6835 of 5 stars2.22$74.53 8.0%183.82%EXELExelixis$45.73+1.9%4.7906 of 5 stars2.52$45.22 -1.1%21Positive NewsAnalyst Forecast3.65%EXASExact Sciences$53.86+3.8%4.7694 of 5 stars2.95$70.50 30.9%22Positive News3.58%MTDMettler-Toledo International$1,205.43-1.5%4.0312 of 5 stars2.45$1,280.90 6.3%11Positive News3.55%NTRANatera$161.06+0.4%1.6551 of 5 stars3.00$184.63 14.6%153.46%ONCBeOne Medicines$252.17+0.7%3.4466 of 5 stars3.00$320.67 27.2%6Analyst DowngradeInsider Trade3.45%GMABGenmab A/S$21.38-0.1%3.9849 of 5 stars2.67$37.80 76.8%12Analyst Upgrade3.45%BIIBBiogen$133.25-0.7%4.8245 of 5 stars2.38$188.48 41.4%32Analyst Revision3.44%BNTXBioNTech$111.05-1.6%1.6348 of 5 stars2.83$137.91 24.2%183.41%WATWaters$311.03-11.9%4.832 of 5 stars2.61$388.94 25.0%18Trending NewsAnalyst ForecastGap DownHigh Trading Volume3.40%BRKRBruker$42.72-2.5%4.8538 of 5 stars2.40$52.89 23.8%10Positive News3.39%CORTCorcept Therapeutics$71.97+0.1%4.8139 of 5 stars3.00$138.25 92.1%53.34%ALKSAlkermes$30.10-0.6%4.8086 of 5 stars2.83$40.00 32.9%12Positive News3.29%MRNAModerna$33.06-1.7%4.3019 of 5 stars2.04$46.61 41.0%25Analyst Forecast3.25%GILDGilead Sciences$111.80+2.0%4.9307 of 5 stars2.77$111.38 -0.4%26Positive News3.16%UTHRUnited Therapeutics$295.29-0.1%4.9895 of 5 stars2.69$383.08 29.7%13Positive News3.16%RGENRepligen$122.57-5.9%4.6594 of 5 stars2.69$170.75 39.3%133.05%AMGNAmgen$295.54+0.1%4.4393 of 5 stars2.35$307.82 4.2%23Positive News3.02%ARGXargenex$568.88+1.5%4.4254 of 5 stars3.10$728.06 28.0%21Positive News2.98%BMRNBioMarin Pharmaceutical$58.81+1.2%4.945 of 5 stars2.75$93.61 59.2%24Positive News2.94%REGNRegeneron Pharmaceuticals$569.62+0.3%4.8312 of 5 stars2.80$814.57 43.0%25Analyst Forecast2.86%VRTXVertex Pharmaceuticals$474.03+1.1%4.3255 of 5 stars2.54$511.62 7.9%28Positive News2.73%HALOHalozyme Therapeutics$57.50+0.6%4.8282 of 5 stars2.17$62.50 8.7%122.70%KRYSKrystal Biotech$149.59+1.0%4.6617 of 5 stars3.00$213.75 42.9%9Insider TradeAnalyst Revision2.64%VCYTVeracyte$27.09+0.0%3.5804 of 5 stars2.70$40.90 51.0%101.06%SRPTSarepta Therapeutics$19.44+7.0%4.7152 of 5 stars2.44$58.54 201.2%25Analyst Revision This page (NYSEARCA:FBT) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust NYSE Arca Biotechnology Index Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust NYSE Arca Biotechnology Index Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
